Ocugen (OCGN) is a clinical-stage biotech focused on modifier gene therapies for inherited retinal diseases, with key ...

Moderately bullish activity in Palantir Technologies (PLTR), with shares up $2.52, or 1.4%, near $181.84. Options volume roughly in line with ...

Revenue-- $190,000 for the three months ended July 31, 2025, a 34% increase over the same period in 2024, driven by higher portal fees and service revenues exchanged for equity securities. Operating ...

Option traders moderately bearish in Alphabet Class A (GOOGL), with shares down $1.37 near $251.16. Options volume relatively light with 144k ...

You ever walk into a NASCAR race and think, “Man, this place used to be packed to the rafters—what happened?” That’s the ...

When investors hear things like "most significant" and "new frontier," they expect it to serve as a catalyst for new growth.